1. Home
  2. SSSS vs TKNO Comparison

SSSS vs TKNO Comparison

Compare SSSS & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SuRo Capital Corp.

SSSS

SuRo Capital Corp.

N/A

Current Price

$9.10

Market Cap

223.3M

Sector

Finance

ML Signal

N/A

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

N/A

Current Price

$4.68

Market Cap

236.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSSS
TKNO
Founded
2010
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
223.3M
236.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SSSS
TKNO
Price
$9.10
$4.68
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$10.13
N/A
AVG Volume (30 Days)
161.5K
123.4K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
10.92%
N/A
EPS Growth
N/A
N/A
EPS
2.61
N/A
Revenue
$2,354,933.00
$39,801,000.00
Revenue This Year
$7,183.09
$8.79
Revenue Next Year
N/A
$10.52
P/E Ratio
$3.51
N/A
Revenue Growth
N/A
9.50
52 Week Low
$4.21
$3.94
52 Week High
$10.34
$10.37

Technical Indicators

Market Signals
Indicator
SSSS
TKNO
Relative Strength Index (RSI) 41.88 48.65
Support Level $9.36 $4.53
Resistance Level $9.60 $4.82
Average True Range (ATR) 0.28 0.24
MACD -0.03 0.02
Stochastic Oscillator 9.58 50.94

Price Performance

Historical Comparison
SSSS
TKNO

About SSSS SuRo Capital Corp.

SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Share on Social Networks: